Navigation Links
Scientists find Achilles' heel in life-threatening malaria parasites
Date:4/20/2012

Scientists have identified a link between different strains of malaria parasites that cause severe disease, which could help develop vaccines or drugs against life-threatening cases of the infection.

Researchers have identified a key protein that is common to many potentially fatal forms of the condition, and found that antibodies that targeted this protein were effective against these severe malaria strains.

The protein has sticky properties that enable it to bind to red blood cells and form dangerous clumps that can block blood vessels. These clumps, or rosettes, can cause severe illness, including coma and brain damage. Presently, between 10 and 20 per cent of people with severe malaria die from it, and the disease which is spread by blood-sucking mosquitoes claims about one million lives per year.

Malaria parasites, once in the bloodstream, are able to alter the protein molecules on their surfaces to evade attack by the immune system. These surface proteins are usually poor targets for treatments or vaccines because they are highly variable between different malaria parasite strains. Now, researchers have found that the surface proteins of rosette-forming parasites share similarities that may allow them to act as a target for treatments to block progress of the disease.

Scientists from the University of Edinburgh worked with collaborators from Cameroon, Mali, Kenya and The Gambia to test their antibodies against parasites collected from patients. The study, published in PLoS Pathogens, was supported by the Wellcome Trust.

Professor Alexandra Rowe of the University of Edinburgh's School of Biological Sciences, who led the study, said: "We knew that clusters, or rosettes, of blood cells were found in many cases of severe or life-threatening malaria, so we looked at rosette-forming parasites and found a common factor that we could target with antibodies. We hope this discovery will inform new treatments or vaccines to block the formation of rosettes and so prevent many life-threatening cases of malaria."


'/>"/>

Contact: Catriona Kelly
catriona.kelly@ed.ac.uk
44-131-651-4401
University of Edinburgh
Source:Eurekalert

Related biology news :

1. Scientists find that neurological changes can happen due to social status
2. Scientists discover switch in plants to create flowers
3. Merkin Family Foundation to fund next generation of Broad Institute scientists
4. Scripps Research Institute scientists develop antidote for cocaine overdose
5. Scientists trace evolutionary history of what mammals eat
6. Scientists find neural stem cell regulator
7. Scientists identify FLT3 gene as a valid therapeutic target in acute myeloid leukemia
8. Scientists complete first-ever emperor penguin count from space
9. Scientists count penguins from space
10. Researchers use game to change how scientists study disease outbreaks
11. Salk scientists redraw the blueprint of the bodys biological clock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... News solutions for biometrics, bag drop and ... ... to 16 March, Materna will present its complete end-to-end passenger ... is a real benefit for passengers. To accelerate the whole ... touch point solutions to take passengers through the complete integrated ...
(Date:2/24/2017)... BARCELONA, Spain , Feb. 24, 2017  EyeLock LLC, ... will demonstrate its elite iris biometric solution on ... with X16 LTE at Mobile World Congress ... in Qualcomm,s Booth in Hall 3, Stand ... contains the Qualcomm Haven™ security platform—a combination ...
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... Calif. , March 24, 2017   Sienna ... and aesthetics company, today announced that Richard Peterson ... effective March 24.   Peterson, who brings more ... John Smither , who is retiring at the ... in an advisory capacity. Peterson joins Sienna from Novan, ...
(Date:3/23/2017)...  Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a ... solid tumor cancers, today announced that yesterday it ... last Friday, March 17, 2017. ... totaling 28,843,692 shares, comprised of 18,843,692 common shares ... Class C Warrants pre-funded at the closing at ...
(Date:3/23/2017)... Kineta, Inc., a biotechnology company focused ... immuno-oncology, today announced the discovery and characterization of ... activate interferon response factor 3 (IRF3) via RIG-I ... regression in a murine colon carcinoma mouse model.  ... tumor regression to initial drug treatment were resistant ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as Vice ... applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has spanned ...
Breaking Biology Technology: